Офтальмохирургия. 2021; : 57-62
Закрытоугольная глаукома, иридохрусталиковый блок, цилиохориоидальная отслойка и транзиторная миопия на фоне приема топирамата
https://doi.org/10.25276/0235-4160-2021-1-57-62Аннотация
Топирамат является сульфаниламидным производным и применяется в лечении эпилепсии и мигрени. В зарубежной научной литературе имеются сообщения о развитии двусторонней закрытоугольной глаукомы, миопического сдвига с цилиохориоидальным выпотом на фоне приема топирамата.
Цель. Оценить эффективность лазерной иридэктомии у пациентки с закрытоугольной глаукомой, транзиторной миопией и двусторонней цилиохориоидальной отслойкой, возникших на фоне приема топирамата.
Материал и методы. Под наблюдением находилась пациентка с диагнозом: OU Закрытоугольная глаукома, иридохрусталиковый блок, цилиохориоидальная отслойка, транзиторная миопия (на фоне приема топирамата). С целью купирования иридохрусталикового блока, цилиохориоидальной отслойки, нормализации уровня офтальмотонуса и восстановления зрительных функций была проведена лазерная иридэктомия на обоих глазах по стандартной технологии с помощью Nd-YAG-лазера Selecta Trio фирмы Lumenis Ltd. (Израиль).
Результаты. После проведения лазерной иридэктомии наблюдались снижение уровня внутриглазного давления (ВГД), постепенное рассасывание хориоидального выпота и разрешение индуцированного миопического сдвига.
Заключение. Лазерная иридэктомия в качестве лечения топирамат-индуцированной закрытоугольной глаукомы может рассматриваться как эффективный и безопасный метод лечения, способствующий быстрому купированию иридохрусталикового блока, цилиохориоидальной отслойки, нормализации уровня ВГД и повышению зрительных функций.
Список литературы
1. Kapcala LP. Clinical Review. NDA 20505/20844. Topamax/topiramate. 2011.
2. Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004;137(1): 193–195. doi: 10.1016/S0002-9394(03)00774-8
3. Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol. 2001;132(1): 112–114. doi: 10.1016/s0002-9394(01)01013-3
4. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angleclosure glaucoma. Ophthalmology. 2004;111: 109–111. doi: 10.1016/j.ophtha.2003.04.004
5. Willett MC, Edward DP. Refractory topiramateinduced angle-closure glaucoma in a man: a case report. J Med Case Rep. 2011;5: 33. doi: 10.1186/1752-1947-5-33
6. Senthil S, Garudadri C, Rao HB, Maheshwari R. Bilateral simultaneous acute angle closure caused by sulphonamide derivatives: a case series. Indian J Ophthalmol. 2010;58: 248–252. doi: 10.4103/0301-4738.62657
7. Dhar SK, Sharma V, Kapoor G, Seshadri KP, Chauhan VS. Topiramate induced bilateral anterior uveitis with choroidal detachment and angle closure glaucoma. Med J Armed Forces India. 2015;71: 88–91. doi: 10.1016/j.mjafi.2012.07.019
8. Katsimpris JM, Katsimpris A, Theoulakis PE, Lepidas J, Petropoulos IK. Bilateral severe anterior uveitis and acute angle-closure glaucoma following topiramate use for migraine crisis. Klin Monbl Augenheilkd. 2014;231: 439–441. doi: 10.1055/s-0034-1368282
9. Acharya N, Nithyanandam S, Kamat S. Topiramate-associated bilateral anterior uveitis and angle closure glaucoma. Indian J Ophthalmol. 2010;58: 557–559. doi: 10.4103/0301-4738.71700
10. DaCosta J, Younis S. Topiramate-induced maculopathy in IgG4-related disease. Drug Healthc Patient Saf. 2016;8: 59–63. doi: 10.2147/DHPS.S105962
11. Goldberg JL, Lau AG, Fan B, Ford L, Greenberg HE. Is uveitis associated with topiramate use? A cumulative review. Clin Ophthalmol. 2016;10: 1467–1470. doi: 10.2147/OPTH.S104847
12. Abtahi M-A, Abtahi S-H, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, Akbari M. Topiramate and the vision: a systematic review. Clin Ophthalmol. 2012;6: 117. doi: 10.2147/OPTH.S27695
13. Singh SK, Thapa SS, Badhu BP. Topiramate induced bilateral angle-closure glaucoma. Kathmandu Univ Med J (KUMJ). 2007;5(2): 234–236.
14. Spaccapelo L, Leschiutta S, Aurea C, Ferrari A. Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report. Cases J. 2009;2(1): 87. doi: 10.1186/1757-1626-2-87
15. Sen HA, O’Halloran HS, Lee WB. Case reports and small case series: topiramate-induced acute myopia and retinal striae. Arch Ophthalmol. 2001;119(5): 775–777.
16. Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001;119(8): 1210–1211.
17. Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 2001;119(11): 1721–1723.
18. Ikeda N, Ikeda T, Nagata M, Mimura O. Ciliochoroidal effusion syndrome induced by sulfa derivatives. Arch Ophthalmol. 2002;120(12): 1775. doi: 10.1001/archopht.120.12.1775
19. Kwon SJ, Park DH, Shin JP. Bilateral transient myopia, angle-closure glaucoma, and choroidal detachment induced by methazolamide. Jpn J Ophthalmol. 2012;56(5): 515–517. doi: 10.1007/s10384-012-0159-y
20. Aref AA, Sayyad FE, Ayres B, Lee RK. Acute bilateral angle closure glaucoma induced by methazolamide. Clin Ophthalmol. 2013;7: 279–282. doi: 10.2147/OPTH.S41540
21. Van Issum C, Mavrakanas N, Schutz JS, Shaarawy T. Topiramate-induced acute bilateral angle closure and myopia: pathophysiology and treatment controversies. Eur J Ophthalmol. 2011;21(4): 404–409. doi: 10.5301/EJO.2010.5979
22. Ikeda N, Ikeda T, Nagata M, Mimura O. Pathogenesis of transient high myopia after blunt eye trauma. Ophthalmology. 2002;109(3):501–507. doi: 10.1016/s0161-6420(01)00995-2
23. Kang YK, Son BJ, Park DH, Shin JP Angiographic features of drug-induced bilateral angle closure and transient myopia with Ciliochoroidal effusion. BMC Ophthalmol. 2019;19(1): 213. doi: 10.1186/s12886-019-1230-y
24. Gubbay SS. The occurrence of drug-induced myopia as a transient side effect of topiramate. Epilepsia. 1998;39(4): 451. doi: 10.1111/j.1528-1157.1998.tb01401.x
25. Cole KL, Wang EE, Aronwald RM. Bilateral acute angle-closure glaucoma in a migraine patient receiving topiramate: a case report. J Emerg Med. 2009;43(2): e89–91. doi: 10.1016/j.jemermed.2009.09.020
26. Gawley SD. Topiramate induced acute transient myopia: a case report. Cases J. 2009;2: 7430. doi: 10.4076/1757-1626-2-7430
27. Rhee DJ, Ramos-Esteban JC, Nipper KS. Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol. Am J Ophthalmol. 2006;141(6): 1133–1134. doi: 10.1016/j.ajo.2006.01.021
28. Parikh R, Parikh S, Das S, Thomas R. Choroidal drainage in the management of acute angle closure after topiramate toxicity. J Glaucoma. 2007;16(8): 691–693. doi: 10.1097/IJG.0b013e318098739b
29. Jabbarpoor Bonyadi MH, Soheilian R, Soheilian M. Topiramate-induced bilateral anterior uveitis associated with hypopyon formation. Ocul. Immunol Inflamm. 2011;19(1): 86–88. doi: 10.3109/09273948.2010.523805
30. DE Oliveira BMR, Ferrari PV, Herrerias BT, Hirai FE, Gracitelli CPB. The use of topiramate for weight loss causing acute glaucoma: a case report and literature review. Med Hypothesis Discov Innov Ophthalmol. 2019;8(2): 116–120.
31. Razeghinejad MR, Pro MJ, Katz LJ. Non-steroidal drug-induced glaucoma. Eye (Lond). 2011;25(8): 971–980. doi: 10.1038/eye.2011.128
32. Levy J, Yagev R, Petrova A, Lifshitz T. Topiramateinduced bilateral angle-closure glaucoma. Can J Ophthalmol. 2006;41(2): 221–225. doi: 10.1139/I06-012
33. Guier CP. Elevated intraocular pressure and myopic shift linked to topiramate use. Optom Vis Sci. 2007;84(12): 1070–1073. doi: 10.1097/OPX.0b013e31815b9e38
34. Rodriguez-Gomez D, Castro-Perez A, Landaluce-Chaves ML, Cid-Rodriguez MC, Lustres-Perez M, Gomez-Fernandez RC. Narrow-angle glaucoma and acute myopia from using topiramate as prophylactic treatment of migraine. Rev Neurol. 2007; 45(4): 254.
35. Zalta AH, Smith RT. Peripheral iridoplasty efficacy in refractory topiramate-associated bilateral acute angle-closure glaucoma. Arch Ophthalmol. 2008;126(11): 1603–1605. doi: 10.1001/archopht.126.11.1603
36. Sbeity Z, Gvozdyuk N, Amde W, Liebmann JM, Ritch R. Argon laser peripheral iridoplasty for topiramate-induced bilateral acute angle closure. J Glaucoma. 2009;18(4): 269–271. doi: 10.1097/IJG.0b013e31818159e9
Fyodorov Journal of Ophthalmic Surgery. 2021; : 57-62
Angle-closure glaucoma, iris-lens contact, ciliochoroidal effusion, and transient myopia induced by topiramate
https://doi.org/10.25276/0235-4160-2021-1-57-62Abstract
Topiramate is a sulphonamide derivative indicated in the treatment of epilepsy and migraine. In foreign scientific literature there are reported cases of topiramate-induced bilateral angle-closure glaucoma and acute myopia with ciliochoroidal effusion.
Purpose. To evaluate outcomes of laser iridectomy in a patient with topiramate-induced angle-closure glaucoma and acute myopia with ciliochoroidal effusion.
Material and methods. A case is reported of bilateral angle-closure glaucoma, iris-lens contact, ciliochoroidal detachment and acute myopia following topiramate for migraine treatment in a 32-year-old patient. Laser peripheral iridectomy was performed in the both eyes according to the standard technology (Nd:YAG laser Selecta Trio, Lumenis Ltd., Israel) to decrease IOP and restore visual functions.
Results. After laser iridectomy, the examination showed normal IOP with no medication, ciliochoroidal effusion and induced myopic shift were relieved.
Conclusion. Laser iridectomy is an effective and safe in the treatment of topiramate-induced angle-closure glaucoma, acute myopia, and ciliochoroidal detachment. It contributes to normalization of IOP and improvement of visual acuity.
References
1. Kapcala LP. Clinical Review. NDA 20505/20844. Topamax/topiramate. 2011.
2. Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004;137(1): 193–195. doi: 10.1016/S0002-9394(03)00774-8
3. Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol. 2001;132(1): 112–114. doi: 10.1016/s0002-9394(01)01013-3
4. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angleclosure glaucoma. Ophthalmology. 2004;111: 109–111. doi: 10.1016/j.ophtha.2003.04.004
5. Willett MC, Edward DP. Refractory topiramateinduced angle-closure glaucoma in a man: a case report. J Med Case Rep. 2011;5: 33. doi: 10.1186/1752-1947-5-33
6. Senthil S, Garudadri C, Rao HB, Maheshwari R. Bilateral simultaneous acute angle closure caused by sulphonamide derivatives: a case series. Indian J Ophthalmol. 2010;58: 248–252. doi: 10.4103/0301-4738.62657
7. Dhar SK, Sharma V, Kapoor G, Seshadri KP, Chauhan VS. Topiramate induced bilateral anterior uveitis with choroidal detachment and angle closure glaucoma. Med J Armed Forces India. 2015;71: 88–91. doi: 10.1016/j.mjafi.2012.07.019
8. Katsimpris JM, Katsimpris A, Theoulakis PE, Lepidas J, Petropoulos IK. Bilateral severe anterior uveitis and acute angle-closure glaucoma following topiramate use for migraine crisis. Klin Monbl Augenheilkd. 2014;231: 439–441. doi: 10.1055/s-0034-1368282
9. Acharya N, Nithyanandam S, Kamat S. Topiramate-associated bilateral anterior uveitis and angle closure glaucoma. Indian J Ophthalmol. 2010;58: 557–559. doi: 10.4103/0301-4738.71700
10. DaCosta J, Younis S. Topiramate-induced maculopathy in IgG4-related disease. Drug Healthc Patient Saf. 2016;8: 59–63. doi: 10.2147/DHPS.S105962
11. Goldberg JL, Lau AG, Fan B, Ford L, Greenberg HE. Is uveitis associated with topiramate use? A cumulative review. Clin Ophthalmol. 2016;10: 1467–1470. doi: 10.2147/OPTH.S104847
12. Abtahi M-A, Abtahi S-H, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, Akbari M. Topiramate and the vision: a systematic review. Clin Ophthalmol. 2012;6: 117. doi: 10.2147/OPTH.S27695
13. Singh SK, Thapa SS, Badhu BP. Topiramate induced bilateral angle-closure glaucoma. Kathmandu Univ Med J (KUMJ). 2007;5(2): 234–236.
14. Spaccapelo L, Leschiutta S, Aurea C, Ferrari A. Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report. Cases J. 2009;2(1): 87. doi: 10.1186/1757-1626-2-87
15. Sen HA, O’Halloran HS, Lee WB. Case reports and small case series: topiramate-induced acute myopia and retinal striae. Arch Ophthalmol. 2001;119(5): 775–777.
16. Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001;119(8): 1210–1211.
17. Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 2001;119(11): 1721–1723.
18. Ikeda N, Ikeda T, Nagata M, Mimura O. Ciliochoroidal effusion syndrome induced by sulfa derivatives. Arch Ophthalmol. 2002;120(12): 1775. doi: 10.1001/archopht.120.12.1775
19. Kwon SJ, Park DH, Shin JP. Bilateral transient myopia, angle-closure glaucoma, and choroidal detachment induced by methazolamide. Jpn J Ophthalmol. 2012;56(5): 515–517. doi: 10.1007/s10384-012-0159-y
20. Aref AA, Sayyad FE, Ayres B, Lee RK. Acute bilateral angle closure glaucoma induced by methazolamide. Clin Ophthalmol. 2013;7: 279–282. doi: 10.2147/OPTH.S41540
21. Van Issum C, Mavrakanas N, Schutz JS, Shaarawy T. Topiramate-induced acute bilateral angle closure and myopia: pathophysiology and treatment controversies. Eur J Ophthalmol. 2011;21(4): 404–409. doi: 10.5301/EJO.2010.5979
22. Ikeda N, Ikeda T, Nagata M, Mimura O. Pathogenesis of transient high myopia after blunt eye trauma. Ophthalmology. 2002;109(3):501–507. doi: 10.1016/s0161-6420(01)00995-2
23. Kang YK, Son BJ, Park DH, Shin JP Angiographic features of drug-induced bilateral angle closure and transient myopia with Ciliochoroidal effusion. BMC Ophthalmol. 2019;19(1): 213. doi: 10.1186/s12886-019-1230-y
24. Gubbay SS. The occurrence of drug-induced myopia as a transient side effect of topiramate. Epilepsia. 1998;39(4): 451. doi: 10.1111/j.1528-1157.1998.tb01401.x
25. Cole KL, Wang EE, Aronwald RM. Bilateral acute angle-closure glaucoma in a migraine patient receiving topiramate: a case report. J Emerg Med. 2009;43(2): e89–91. doi: 10.1016/j.jemermed.2009.09.020
26. Gawley SD. Topiramate induced acute transient myopia: a case report. Cases J. 2009;2: 7430. doi: 10.4076/1757-1626-2-7430
27. Rhee DJ, Ramos-Esteban JC, Nipper KS. Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol. Am J Ophthalmol. 2006;141(6): 1133–1134. doi: 10.1016/j.ajo.2006.01.021
28. Parikh R, Parikh S, Das S, Thomas R. Choroidal drainage in the management of acute angle closure after topiramate toxicity. J Glaucoma. 2007;16(8): 691–693. doi: 10.1097/IJG.0b013e318098739b
29. Jabbarpoor Bonyadi MH, Soheilian R, Soheilian M. Topiramate-induced bilateral anterior uveitis associated with hypopyon formation. Ocul. Immunol Inflamm. 2011;19(1): 86–88. doi: 10.3109/09273948.2010.523805
30. DE Oliveira BMR, Ferrari PV, Herrerias BT, Hirai FE, Gracitelli CPB. The use of topiramate for weight loss causing acute glaucoma: a case report and literature review. Med Hypothesis Discov Innov Ophthalmol. 2019;8(2): 116–120.
31. Razeghinejad MR, Pro MJ, Katz LJ. Non-steroidal drug-induced glaucoma. Eye (Lond). 2011;25(8): 971–980. doi: 10.1038/eye.2011.128
32. Levy J, Yagev R, Petrova A, Lifshitz T. Topiramateinduced bilateral angle-closure glaucoma. Can J Ophthalmol. 2006;41(2): 221–225. doi: 10.1139/I06-012
33. Guier CP. Elevated intraocular pressure and myopic shift linked to topiramate use. Optom Vis Sci. 2007;84(12): 1070–1073. doi: 10.1097/OPX.0b013e31815b9e38
34. Rodriguez-Gomez D, Castro-Perez A, Landaluce-Chaves ML, Cid-Rodriguez MC, Lustres-Perez M, Gomez-Fernandez RC. Narrow-angle glaucoma and acute myopia from using topiramate as prophylactic treatment of migraine. Rev Neurol. 2007; 45(4): 254.
35. Zalta AH, Smith RT. Peripheral iridoplasty efficacy in refractory topiramate-associated bilateral acute angle-closure glaucoma. Arch Ophthalmol. 2008;126(11): 1603–1605. doi: 10.1001/archopht.126.11.1603
36. Sbeity Z, Gvozdyuk N, Amde W, Liebmann JM, Ritch R. Argon laser peripheral iridoplasty for topiramate-induced bilateral acute angle closure. J Glaucoma. 2009;18(4): 269–271. doi: 10.1097/IJG.0b013e31818159e9
